Home

Peter A Kiener

CIK 1328146 · Chief Science Officer · last filed 2026-01-06

Peter A Kiener is a Chief Science Officer who has filed 34 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for CUE, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$8.4K

Companies

4

Total Filings

34

Lifetime Open-Market Net

-$1.22M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CUE Director 323 $26.10 $8.4K -$392.3K 11 2026-01-06
LAVA Therapeutics NV (LVTX) Delisted Director — $1.74 — $0 2 2025-11-17
PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Director — $13.60 — $0 7 2023-06-23
Sucampo Pharmaceuticals, Inc. (SCMP) Delisted Chief Science Officer 0 — — -$825.0K 14 2018-02-13

Recent Filings

34 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-06 CUE Grant (A) — $0 EDGAR
2025-11-17 LAVA Therapeutics NV (LVTX) Delisted Disp (D) — $0 EDGAR
2025-02-18 LAVA Therapeutics NV (LVTX) Delisted Grant (A) — $0 EDGAR
2025-01-03 CUE Grant (A) — $0 EDGAR
2024-01-04 CUE Grant (A) — $0 EDGAR
2023-06-23 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) — $0 EDGAR
2023-03-27 CUE Mixed +357 -$2.9K EDGAR
2023-01-05 CUE Grant (A) — $0 EDGAR
2022-06-24 PALVELLA THERAPEUTICS, INC. (PIRS) Delisted Grant (A) — $0 EDGAR
2022-01-05 CUE Grant (A) — $0 EDGAR
Showing 1–10 of 34
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.